Harvard Medical School researchers developed an artificial intelligence tool capable of real-time differentiation between glioblastoma and mimicking brain tumors during surgical procedures. This innovation offers unprecedented diagnostic precision, empowering surgeons with immediate actionable insights to optimize resection strategies. The AI platform integrates seamlessly in operative settings, potentially improving outcomes by tailoring interventions precisely to tumor biology and ensuring maximal safe tumor removal.